CARA THERAPEUTICS INC (CARA)
US1407551092 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 51.77M | 63.70M | 13.50M | 31.70M | 18.30M | |||
| Marketable Securities | 48.98M | 81.70M | 153.60M | 149.20M | 136.70M | |||
| Receivables | 4.02M | 4.50M | 1.20M | 2.10M | 1.80M | |||
| Inventories | 2.82M | 2.40M | 2.60M | N/A | N/A | |||
| Other Current Assets | 8.56M | 16.70M | 2.50M | 12.10M | 8.90M | |||
| Total Current Assets | 116.16M | 168.90M | 173.30M | 195.10M | 165.70M | |||
| Non-Current Assets | ||||||||
| PPE Net | 8.19M | 2.00M | 3.60M | 5.10M | 3.70M | |||
| Investments And Advances | 0.00 | 11.40M | 69.80M | 70.60M | 63.20M | |||
| Other Non-Current Assets | 1.50M | 0.00 | 400.00K | 400.00K | 400.00K | |||
| Total Non-Current Assets | 9.69M | 13.30M | 73.80M | 76.10M | 67.30M | |||
| TOTAL ASSETS | 125.84M | 182.20M | 247.10M | 271.20M | 233.00M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 14.01M | 13.90M | 12.00M | 13.60M | 11.50M | |||
| Accounts Payable | 11.58M | 9.60M | 5.60M | 4.90M | 9.10M | |||
| Other Current Liabilities | N/A | N/A | N/A | 0.00 | 22.30M | |||
| Total Current Liabilities | 25.59M | 23.50M | 17.60M | 18.50M | 42.90M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 43.17M | 0.00 | 1.90M | 3.70M | 3.40M | |||
| Total Non-Current Liabilities | 43.17M | 0.00 | 1.90M | 3.70M | 3.30M | |||
| TOTAL LIABILITIES | 68.76M | 23.50M | 19.50M | 22.20M | 46.20M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -684.75M | -566.20M | -480.80M | -392.30M | -400.70M | |||
| Additional Paid In Capital | 742.04M | 726.60M | 708.60M | 641.20M | 587.20M | |||
| Common Shares | 54.00K | 100.00K | 100.00K | 100.00K | 0.00 | |||
| Other Shareholders' Equity | -260.00K | -1.70M | -400.00K | 100.00K | 200.00K | |||
| Shares Outstanding | 54.48M | 53.80M | 53.50M | 49.90M | 46.70M | |||
| Tangible Book Value per Share | 1.05 | 2.95 | 4.25 | 4.99 | 4.00 | |||
| Total Shareholders' Equity | 57.09M | 158.80M | 227.50M | 249.00M | 186.70M | |||
| TOTAL LIABILITIES AND EQUITY | 125.84M | 182.20M | 247.10M | 271.20M | 233.00M | |||
| Statistics | ||||||||
| Current Ratio | 4.54 | 7.19 | 9.85 | 10.55 | 3.86 | |||
| Return On Assets (ROA) | -94.17% | -46.93% | -35.77% | 3.10% | -45.67% | |||
| Return On Equity (ROE) | -207.61% | -53.84% | -38.86% | 3.37% | -56.99% | |||
| Return On Invested Capital (ROIC) | N/A | N/A | N/A | 1.69% | N/A | |||
| Return On Invested Capital Ex Cash (ROICexc) | N/A | N/A | N/A | 5.94% | N/A | |||
| Return On Invested Capital Ex Cash + Goodwill (ROICexcg) | N/A | N/A | N/A | 5.94% | N/A | |||
All data in USD